港股异动 | 复旦张江(01349)涨超12% ADC平台研发进展顺利光动力平台项目加速进行

智通财经2025-07-17

智通财经APP获悉，复旦张江(01349)涨超12%，截至发稿，涨12.21%，报4.32港元，成交额2.45亿港元。消息面上，近日，复旦张江在投资者关系活动记录表中披露，公司ADC平台研发进展顺利。治疗三阴乳腺癌、膀胱癌、胃癌等多种肿瘤的抗Trop2抗体偶联药物已在ASCO官网发表了I期临床研究数据结果，针对TNBC适应症的III期临床研究正在进行中。此外，基于全新linker-drug平台...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2552174909?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-17 09:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2552174909","market":"sh","top_or_hot":-1,"title":"港股异动 | 复旦张江(01349)涨超12% ADC平台研发进展顺利 光动力平台项目加速进行","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，复旦张江(01349)涨超12%，截至发稿，涨12.21%，报4.32港元，成交额2.45亿港元。消息面上，近日，复旦张江在投资者关系活动记录表中披露，公司ADC平台研发进展顺利。治疗三阴乳腺癌、膀胱癌、胃癌等多种肿瘤的抗Trop2抗体偶联药物已在ASCO官网发表了I期临床研究数据结果，针对TNBC适应症的III期临床研究正在进行中。此外，基于全新linker-drug平台...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1318800.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 复旦张江(01349)涨超12% ADC平台研发进展顺利 光动力平台项目加速进行</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 复旦张江(01349)涨超12% ADC平台研发进展顺利 光动力平台项目加速进行\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-17 09:52 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1318800.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，复旦张江(01349)涨超12%，截至发稿，涨12.21%，报4.32港元，成交额2.45亿港元。消息面上，近日，复旦张江在投资者关系活动记录表中披露，公司ADC平台研发进展顺利。治疗三阴乳腺癌、膀胱癌、胃癌等多种肿瘤的抗Trop2抗体偶联药物已在ASCO官网发表了I期临床研究数据结果，针对TNBC适应症的III期临床研究正在进行中。此外，基于全新linker-drug平台...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1318800.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1318800.html","article_id":"2552174909","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2552174909","pubTimestamp":1752717129,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，复旦张江涨超12%，截至发稿，涨12.21%，报4.32港元，成交额2.45亿港元。消息面上，近日，复旦张江在投资者关系活动记录表中披露，公司ADC平台研发进展顺利。治疗三阴乳腺癌、膀胱癌、胃癌等多种肿瘤的抗Trop2抗体偶联药物已在ASCO官网发表了I期临床研究数据结果，针对TNBC适应症的III期临床研究正在进行中。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688505":"复旦张江","BK1191":"制药","ADC":"艾格里房产","01349":"复旦张江","BK0239":"医药制造","BK4231":"零售房地产信托","BK4080":"零售业房地产投资信托"},"translate_title":"Changes in Hong Kong stocks | Fudan Zhangjiang (01349) rose more than 12%, ADC platform research and development is progressing smoothly, photodynamic platform project is accelerating","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688505":1,"01349":1,"ADC":1},"content_text":"智通财经APP获悉，复旦张江(01349)涨超12%，截至发稿，涨12.21%，报4.32港元，成交额2.45亿港元。消息面上，近日，复旦张江在投资者关系活动记录表中披露，公司ADC平台研发进展顺利。治疗三阴乳腺癌、膀胱癌、胃癌等多种肿瘤的抗Trop2抗体偶联药物已在ASCO官网发表了I期临床研究数据结果，针对TNBC适应症的III期临床研究正在进行中。此外，基于全新linker-drug平台BB05，多个ADC项目如抗DLL3抗体偶联药物、抗Her2抗体偶联药物等也取得了积极成果，其中抗DLL3抗体偶联药物在动物体内展现了强效的抗肿瘤活性，起效剂量低于1.5mg/kg，安全性良好。此外，光动力技术平台方面，盐酸氨酮戊酸颗粒剂用于非肌层浸润性膀胱癌手术切除辅助项目的验证性临床试验已完成首例受试者入组，盐酸氨酮戊酸口服溶液用粉末用于高级别脑胶质瘤术中可视化的验证性临床试验入组基本结束，即将递交上市申请。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2552174909","isCrawlerRequest":true}

港股异动 | 复旦张江(01349)涨超12% ADC平台研发进展顺利 光动力平台项目加速进行

精彩评论

港股异动 | 复旦张江(01349)涨超12% ADC平台研发进展顺利光动力平台项目加速进行